Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation
Clinical trial NCT00261378 · COMPLETED
Trial details
- NCT number
- NCT00261378
- Sponsor
- Boston Scientific Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-01-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.